If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGulf Marine Services Regulatory News (GMS)

Share Price Information for Gulf Marine Services (GMS)

Share Price is delayed by 15 minutes
Get Live Data
18.08    0.00 (0.00%)
Bid:
18.06
Ask:
18.18
Spread: 0.12 (0.664%)
Market Cap: £208.31m
GMS Live PriceLast checked at - London Stock Exchange

Intraday Gulf Marine Services Share Chart

Form 8.1 - Gulf Marine Services PLC

6 May 2020 08:12

RNS Number : 1025M
Seafox International Limited
06 May 2020
Β 

FORM 8 (DD)

Β 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Seafox International Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Gulf Marine Services plc

(d) Status of person making the disclosure:

e.g. offeror, offeree, person acting in concert with the offeror/offeree (specify name of offeror/offeree)

Potential offeror

(e) Date dealing undertaken:

05/05/20

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES / NO / N/A

If YES, specify which: N/A

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

57,455,169

16.39

N/A

N/A

(2) Cash-settled derivatives:

Β 

N/A

N/A

N/A

N/A

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

N/A

N/A

N/A

N/A

Β 

TOTAL:

57,455,169

16.39

N/A

N/A

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Ordinary shares

Purchase

Β 

9,388,689

10 pence

Β 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

Β 

Class of relevant security

Purchases/ sales

Β 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

N/A

N/A

N/A

N/A

N/A

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

N/A

N/A

N/A

N/A

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

06/05/20

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DCCUNRBRRVUVRRR
Date   Source Headline
18th Jul 20237:00 amRNSDecrease in Financing Charges
12th Jun 20237:00 amRNSContract
7th Jun 20231:15 pmRNSResult of AGM
10th May 20234:46 pmRNSDirector / PDMR Shareholdings
4th May 20237:00 amRNSHealth & Safety Milestone
28th Apr 20235:02 pmRNSAnnual Report and Notice of AGM
24th Apr 20237:00 amRNSFinal Results
29th Mar 20237:00 amRNSContract
10th Feb 20237:30 amRNSDirector/PDMR Shareholding
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 20237:00 amRNSContract
13th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSTrading Statement
3rd Jan 20237:00 amRNSIssue of Warrants
14th Dec 20227:00 amRNSWarrant Calculations
9th Dec 20227:00 amRNSTrading Update
25th Nov 202211:37 amRNSHolding(s) in Company
15th Nov 20227:00 amRNSContract
3rd Nov 20227:00 amRNSTwo New Contract Awards and A Contract Extension
19th Oct 20223:10 pmRNSResults of General Meeting
29th Sep 20227:00 amRNSContract
28th Sep 20225:04 pmRNSPublication of Shareholder Circular & Notice of GM
27th Sep 20227:00 amRNSContract
26th Sep 20227:00 amRNSInterim results for the six months ended 30/06/22
1st Sep 20224:40 pmRNSSecond Price Monitoring Extn
1st Sep 20224:35 pmRNSPrice Monitoring Extension
30th Jun 20221:10 pmRNSResult of AGM
15th Jun 20227:30 amRNSGrant of Director Share Awards
7th Jun 20225:30 pmRNS2021 Annual Report and Notice of 2022 AGM
13th May 20227:10 amRNSAnnual Financial Report
29th Apr 20227:00 amRNSContract
17th Feb 20227:00 amRNSContract
7th Feb 20227:00 amRNSAppointment of Chief Financial Officer
1st Feb 20228:09 amRNSDirector/PDMR Shareholding
25th Jan 20227:00 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSTrading Update
21st Dec 20217:00 amRNSContract
20th Dec 20214:41 pmRNSSecond Price Monitoring Extn
20th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:35 pmRNSPrice Monitoring Extension
11th Nov 20217:00 amRNSContract
4th Nov 20214:40 pmRNSSecond Price Monitoring Extn
4th Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20217:00 amRNSContract
13th Oct 20213:17 pmRNSShare Purchase by a Director
13th Oct 20217:00 amRNSHalf-year Report
1st Oct 20217:00 amRNSResults Release Date & Trading Update
23rd Aug 20217:00 amRNSAppointment of Non-Executive Director
8th Jul 20211:08 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.